Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 2/20 | 0.61 |
| ▸ | P4HB | P07237 | 4/20 | 0.49 |
| ▸ | FBP1 | P09467 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.46 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | VNN1 | O95497 | 2/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31575813 | 1.00 | GSK3B (0.61) | GSK3BP4HBFBP1GRM5ALDH1A1 | |
| Fluorobenzene SCHEMBL28928512 | 0.88 | GSK3B (0.50) | GSK3BP4HBFBP1VNN1KAT6A | |
| SCHEMBL2104597 | 0.84 | BRAF (0.56) | GRM5ALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL2164429 | 0.82 | GSK3B (0.62) | GSK3BP4HBGRM5ALDH1A1CLK1 | |
| SCHEMBL103415 | 0.82 | ALDH1A1 (0.47) | GSK3BP4HBFBP1GRM5ALDH1A1 | |
| SCHEMBL60691 | 0.82 | GSK3B (0.62) | GSK3BGRM5 | |
| SCHEMBL29441888 | 0.82 | GSK3B (0.62) | GSK3BGRM5 | |
| Benzoyl Chloride SCHEMBL8174168 | 0.81 | VNN1 (0.46) | GSK3BGRM5KMT2AVNN1IRAK4 | |
| SCHEMBL23079142 | 0.80 | GSK3B (0.61) | GSK3BP4HBGRM5ALDH1A1CLK1 | |
| SCHEMBL14508038 | 0.80 | GSK3B (0.51) | GSK3BP4HBFBP1GRM5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773606-B | Preparation method of selenium-containing hyperbranched polymer with ester bond as core | 湖北宜化新材料科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-114853627-A | Substituted docosahexaenoic acid diethyl ester derivative as well as preparation method and application thereof | 自然资源部第三海洋研究所 | 2022-08-05 | — | — | CN | claimed |
| CN-114773606-A | Preparation method of selenium-containing hyperbranched polymer with ester bond as core | 湖北宜化新材料科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| EP-1721891-A1 | Method for producing cyanophenyl derivatives | Showa Denko Kabushiki Kaisha (JP) | 2006-11-15 | — | — | EP | claimed |
| US-6262292-B1 | FORMING CYANAOBENZALDEHYDE BY OXIDATION OF CYANOBENZYLAMINE | SHOWA DENKO K.K. (JP) | 2001-07-17 | — | — | US | claimed |
| EP-1083165-A1 | PROCESSES FOR PRODUCING CYANOPHENYL DERIVATIVES | Showa Denko Kabushiki Kaisha (JP) | 2001-03-14 | — | — | EP | claimed |
| WO-1993014055-A1 | PREPARATION OF 2,5-DICHLOROBENZOPHENONES | MAXDEM INCORPORATED (US) | 1993-07-22 | — | — | WO | claimed |
| US-5210313-A | Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids | MAXDEM INCORPORATED (US) | 1993-05-11 | — | — | US | claimed |
| CN-122071464-A | Heterocyclic compound, pharmaceutical composition thereof and application thereof | 上海璎黎药业有限公司 | 2026-05-22 | — | — | CN | disclosed |
| CN-122010947-A | Antagonists of adenosine A2a receptors | 阿道尔克斯治疗有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12617796-B2 | Antagonists of the adenosine A2a receptor | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-05 | — | — | US | disclosed |
| US-20260092074-A1 | Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof | GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) | 2026-04-02 | — | — | US | disclosed |
| US-20260022098-A1 | BULLEYACONITINE A DERIVATIVE WITH ANALGESIC ACTIVITY, AND PREPARATION METHOD AND APPLICATION THEREOF | UNIV SOUTHWEST JIAOTONG (CN) | 2026-01-22 | — | — | US | disclosed |
| US-12522614-B2 | Topical phosphoinositide 3-kinase inhibitors | VENTHERA, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-4192890-A | Novel benzoylphenylacetic acid esters | ROUSSEL UCLAF (FR) | 1980-03-11 | — | — | US | disclosed |
| US-4085090-A | Aromatic polymers containing a nitrogen-containing ring group, and process for preparation thereof | TEIJIN LIMITED (JA) | 1978-04-18 | — | — | US | disclosed |
| US-4069224-A | N-(PYRIDYLALKYL)BENZAMIDES, IMPROVE PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-01-17 | — | — | US | disclosed |
| US-4024153-A | ULTRAVIOLET STABILIZERS | EASTMAN KODAK COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-3954706-A | Polychromophoric benzotriazole ultraviolet stabilizers for organic compositions | EASTMAN KODAK COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3939162-A | Anthrapyrimidine dyes | BASF AKTIENGESELLSCHAFT (DT) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022098-A1 | BULLEYACONITINE A DERIVATIVE WITH ANALGESIC ACTIVITY, AND PREPARATION METHOD AND APPLICATION THEREOF | OPRD1, OPRM1, OPRK1 | GSK3B 1268/4885P4HB 1108/4885FBP1 3429/4885 |
| US-12617796-B2 | Antagonists of the adenosine A2a receptor | ADORA2A, ADORA2B, ADORA3 | GSK3B 732/4885P4HB 4360/4885FBP1 765/4885 |
| US-20260092074-A1 | Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof | STS, NR5A1, CYP21A2 | GSK3B 3896/4885P4HB 757/4885FBP1 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.